T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0026 (-86.67%)
May 21, 2026, 4:00 PM EST
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $11.22 thousand as of May 22, 2026. Its market cap has decreased by -99.64% in one year.
Market Cap
11.22K
Enterprise Value
n/a
Revenue
7.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 11.22K, a decrease of -100.00%. That is a compound annual growth rate of -57.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 11.22K | -92.00% |
| Dec 31, 2025 | 140.23K | -98.41% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iMD Companies | 3.05M |
| Hypha Labs | 2.67M |
| InVitro International | 1.50M |
| ProPhase Labs | 972.49K |
| IDenta | 714.18K |
| NovelStem International | 542.66K |
| Medical Imaging | 63.82K |
| CardioGenics Holdings | 14.29K |